Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1992 1
1995 1
1999 1
2002 2
2003 1
2004 1
2005 1
2006 4
2007 4
2008 3
2009 4
2010 5
2011 2
2013 3
2014 7
2015 4
2016 9
2017 4
2018 3
2019 4
2020 5
2021 4
2022 8
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Evans DG, Plotkin SR. Legius E, et al. Genet Med. 2021 Aug;23(8):1506-1513. doi: 10.1038/s41436-021-01170-5. Epub 2021 May 19. Genet Med. 2021. PMID: 34012067 Free PMC article.
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
Neurofibromatoses: part 1 - diagnosis and differential diagnosis.
Rodrigues LO, Batista PB, Goloni-Bertollo EM, de Souza-Costa D, Eliam L, Eliam M, Cunha KS, Darrigo-Junior LG, Ferraz-Filho JR, Geller M, Gianordoli-Nascimento IF, Madeira LG, Malloy-Diniz LF, Mendes HM, de Miranda DM, Pavarino EC, Baptista-Pereira L, Rezende NA, Rodrigues Lde O, da Silva CM, de Souza JF, de Souza ML, Stangherlin A, Valadares ER, Vidigal PV. Rodrigues LO, et al. Arq Neuropsiquiatr. 2014 Mar;72(3):241-50. doi: 10.1590/0004-282x20130241. Arq Neuropsiquiatr. 2014. PMID: 24676443 Free article.
Lower fasting blood glucose in neurofibromatosis type 1.
Martins AS, Jansen AK, Rodrigues LO, Matos CM, Souza ML, de Souza JF, Diniz Mde F, Barreto SM, Diniz LM, de Rezende NA, Riccardi VM. Martins AS, et al. Among authors: rodrigues lo. Endocr Connect. 2016 Jan;5(1):28-33. doi: 10.1530/EC-15-0102. Epub 2015 Dec 2. Endocr Connect. 2016. PMID: 26631381 Free PMC article.
Increased resting metabolism in neurofibromatosis type 1.
Souza MLR, Jansen AK, Rodrigues LOC, Vilela DLS, Kakehasi AM, Martins AS, Souza JF, Rezende NA. Souza MLR, et al. Among authors: rodrigues loc. Clin Nutr ESPEN. 2019 Aug;32:44-49. doi: 10.1016/j.clnesp.2019.05.006. Epub 2019 May 24. Clin Nutr ESPEN. 2019. PMID: 31221289
76 results